Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences - 1 Feb 2008

LeVasseur Natalie L, Zhu Hao-Jie, Markowitz John S, DeVane C Lindsay, Patrick Kennerly S

Abstract excerpt

A chiral derivatization gas chromatographic-mass spectrometric (GC-MS) method for urine methylphenidate (MPH) analysis was developed and validated to investigate preliminary findings regarding a novel MPH poor metabolizer (PM). Detection was by electron impact (EI) ionization-selected ion monitor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gas Chromatography-Mass Spectrometry
Share to Methylphenidate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Stereoisomerism

Source

Open in PubMed Open full text

Identifiers

PMID: 18155648
DOI: 10.1016/j.jchromb.2007.11.030
PMCID: PMC2350184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-18155648-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.PMID 18155648Read ↗

Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex.Semantic proximity Read ↗

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants.Semantic proximity Read ↗

Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase.Semantic proximity Read ↗

The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratiosSemantic proximity Read ↗

Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.Semantic proximity Read ↗

Stereoselective determination of the CYP2C19 probe drug mephenytoin in human urine by gas chromatography-mass spectrometry.Semantic proximity Read ↗

Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?Semantic proximity Read ↗

Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHDSemantic proximity Read ↗

High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.Semantic proximity Read ↗

D-Methylphenidate is non-genotoxic in in vitro and in vivo assays.Semantic proximity Read ↗

Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate.Semantic proximity Read ↗

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.